Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000557EBVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20001603HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20029318HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TVIS20031248HPVENSG00000108576.10protein_codingSLC6A4NoNo6532P31645
TCGA Plot Options
Drug Information
GeneSLC6A4
DrugBank IDDB01149
Drug NameNefazodone
Target IDBE0000749
UniProt IDP31645
Regulation Typeinhibitor
PubMed IDs7475971; 9472845; 9537821; 7649970; 9098663
CitationsOwens MJ, Ieni JR, Knight DL, Winders K, Nemeroff CB: The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies. Life Sci. 1995;57(24):PL373-80.@@Narayan M, Anderson G, Cellar J, Mallison RT, Price LH, Nelson JC: Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin. J Clin Psychopharmacol. 1998 Feb;18(1):67-71.@@Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58.@@Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, Wright RN, Yocca FD: Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry. 1995;56 Suppl 6:3-11.@@Davis R, Whittington R, Bryson HM: Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs. 1997 Apr;53(4):608-36.
GroupsApproved; Withdrawn
Direct ClassificationPhenylpiperazines
SMILESCCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Pathways
PharmGKBPA450603
ChEMBLCHEMBL623